Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide in Calfactant for BPD in ELGANs
NCT02907593Phase 2Terminated
- Start
- Sep 2016
- Primary completion
- Apr 2018
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide in bronchopulmonary dysplasia (BPD). Started Sep 2016; status: terminated.
02
Drugs
budesonide
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT02907593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02907593.